首页 › 肝癌（肝细胞癌） › 加利福尼亚州 › Orange
Orange CA 肝癌（肝细胞癌）临床试验
14项针对 肝癌（肝细胞癌）的研究正在 Orange及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
招募中1/2 期
- Research Facility, Orange
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
招募中1/2 期
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
招募中2 期
- UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
招募中1/2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
招募中
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's Hospital of Orange County, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
招募中观察性研究
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
招募中1/2 期
- Children's Hospital Orange County, Orange
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
招募中2 期
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- University of California Irvine Medical Center, Orange
Combination of TATE and PD-1 Inhibitor in Liver Cancer
招募中2 期
- University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Orange
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Los Angeles, CA19 项研究
- Boston, MA18 项研究
- Cleveland, OH18 项研究
- Chicago, IL16 项研究
- Philadelphia, PA16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Jacksonville, FL14 项研究
- San Antonio, TX13 项研究
Orange的其他研究
- 非小细胞肺癌25 项研究
- 转移性癌症20 项研究
- 结直肠癌16 项研究
- 卵巢癌16 项研究
- 胰腺癌15 项研究
- 黑色素瘤14 项研究
- 乳腺癌14 项研究
- 肺癌14 项研究
- 前列腺癌14 项研究
- 胃癌13 项研究
- 癌症（所有类型）13 项研究
- 急性髓系白血病13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。